Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
165.0400 -1.30 (-0.78%)
NSE Sep 30, 2025 15:31 PM
Volume: 791.6K
 

165.04
-0.78%

Marksans Pharma

Centrum Broking
Source: Bloomberg, Centrum Research, *as on 17h November 2017 Recommendation and key risks: We have revised our FY18E and FY19E EPS downwards by 14% and 7% respectively in view of forex losses and increase in crude based raw material prices. We downgrade MPL to Hold from Buy rating, with a TP of Rs45 based on 18x March'19 EPS of Rs2.5, and a 10.7% upside from CMP. Key positive upsides would be additional ANDA approvals from US FDA and key...
Marksans Pharma Ltd. has lost -45.99% in the last 1 Year
More from Marksans Pharma Ltd.
Recommended